Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207167 · ClinicalTrials.gov registry record
Mediators of Atherosclerosis in South Asians Living in America
A clinical trial of Cardiovascular Diseases and Coronary Artery Disease, sponsored by University of California, San Francisco.
- Active
- Registry status
- 2,314
- Enrollment target
- 3
- Study locations
NCT01207167 is a study of Cardiovascular Diseases and Coronary Artery Disease that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 2,314 participants, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01207167, a study of Cardiovascular Diseases and Coronary Artery Disease, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- 2,314 participants
- Enrollment target
- 3
- Study locations
Study Summary
South Asian (Indian, Pakistani, Bangladeshi, Nepali, and Sri Lankan) individuals have high rates of cardiovascular disease that is not explained by traditional cardiovascular risk factors. Though South Asians represent over one-quarter of the world's population, there are no longitudinal studies in this high-risk ethnic group. The investigators aim to establish a longitudinal study of South Asians at three United States centers to identify risk factors linked to subclinical atherosclerosis and incident cardiovascular disease. The purpose of this study is to understand the causes of heart disease and stroke in South Asians and compare these causes to those in other United States ethnic groups.
Conditions Studied
Study Locations (3)
California
- University of California, San Francisco - San Francisco
Illinois
- Northwestern University - Chicago
New York
- New York University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,314 participants |
| Start Date | 2010-09 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207167
The ClinicalTrials.gov registry entry for NCT01207167 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,314 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT01207167 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT01207167 about?
NCT01207167 is a clinical study titled "Mediators of Atherosclerosis in South Asians Living in America". South Asian (Indian, Pakistani, Bangladeshi, Nepali, and Sri Lankan) individuals have high rates of cardiovascular disease that is not explained by traditional cardiovascular risk factors. Though South Asians represent over one-quarter of the world's population, there are no longitudinal studies in ...
What is the current status of trial NCT01207167?
This trial is currently active not recruiting. The enrollment target is 2,314 participants. The study started on 2010-09. Estimated completion is 2027-04.
What conditions does trial NCT01207167 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Heart Diseases, Atherosclerosis, Coronary Disease.
Who is sponsoring clinical trial NCT01207167?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01207167 being conducted?
This trial has 3 study locations across California, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.